Table 2.

TCRN Case Statistics for Numbers of Patients and Cases (A) and the Number of Cases of Rare Tumors (B) and Common Cancer Categories (C) based on final diagnosis.

A. Case Statistics	GRU	RPCI	ACC	UPCI	Total
Patients	76,404	72,376	465,717	1,840,156	2,454,653
Pathology Cases	157,316	156,555	857,681	4,588,017	5,759,569

B. Rare Tumors	GRU	RPCI	ACC	UPCI	Total
Adenoid Cystic Carcinoma	41	88	404	509	1,042
Adrenocortical Carcinoma	5	20	59	63	147
Alveolar Soft Part Sarcoma	3	15	10	25	53
Angioimmunoblastic Lymphadenopathy	12	35	58	84	189
Chordoma	5	14	124	245	388
Follicular Dendritic Cell Sarcoma	2	2	8	13	25
Merkel Cell Carcinoma	9	72	165	196	442
Ovarian Granulosa Cell Tumor	4	10	23	34	71
Phaeochromocytoma	15	38	272	164	489
Pleomorphic Xanthoastrocytoma	2	5	12	53	72
Pseudomyxoma Peritonei	6	36	46	129	217
Rhabdomyosarcoma	34	70	86	270	460
Sebaceous Adenocarcinoma	13	33	26	94	166
Sinonasal Undifferentiated Carcinoma	2	6	31	27	66
Thymoma	13	45	433	210	701

C. Common Cancer Categories	GRU	RPCI	ACC	UPCI	Total
Bladder Carcinoma	345	1,618	3,873	6,711	12,547
Breast Carcinoma	1,143	9,605	28,262	37,691	76,701
Colorectal Carcinoma	465	2,530	6,898	11,608	21,501
Endometrial Carcinoma	394	1,815	3,707	7,706	13,622
Esophageal Carcinoma	63	1,477	2,452	3,514	7,506
Hepatic Carcinoma	153	633	2,912	5,720	9,418
Lung Carcinoma	820	4,264	10,208	17,955	33,247
Lymphoma	1,387	6,795	10,605	15,689	34,476
Malignant Glial Neoplasm	242	292	2,198	4,943	7,675
Malignant Melanoma	335	2,675	5,180	7,068	15,258
Ovarian Carcinoma	503	2,872	4,659	6,446	14,480
Pancreatic Carcinoma	162	740	1,866	3,622	6,390
Prostate Carcinoma	903	3,612	18,867	19,445	42,827
Renal Cell Carcinoma	364	1,319	3,183	10,950	15,816
Thyroid Carcinoma	474	1,236	7,681	12,387	21,778